Skip to content
Portal K.UTB
  • ikona jazykČeština
  • ikona přihlášení Login
logo knihovny
  • TBU Catalog
  • e-resources
  • E-THESES
Advanced Search
  • Corrigendum: The main protease...
Toolbar
  • ikona citování Cite this
  • ikona bookmark Save to List
  • ikona export Export Record
    • Export to CitacePRO
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to RIS
  • ikona email Email this
  • ikona permanent link Permanent link

Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper

[This corrects the article DOI: 10.3389/fbioe.2023.1187761.].[This corrects the article DOI: 10.3389/fbioe.2023.1187761.].

Saved in:
Bibliographic Details
Published inFrontiers in bioengineering and biotechnology Vol. 11; p. 1294266
Main Authors Belenkaya, Svetlana V., Merkuleva, Iuliia A., Yarovaya, Olga I., Chirkova, Varvara Yu, Sharlaeva, Elena A., Shanshin, Daniil V., Volosnikova, Ekaterina A., Vatsadze, Sergey Z., Khvostov, Mikhail V., Salakhutdinov, Nariman F., Shcherbakov, Dmitriy
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 06.11.2023
Subjects
3CL protease
E. coli bacteria
RBD
SARS-CoV-2
TEV protease
Online AccessGet full text

Cover

Loading…
  • More Information
  • Comments
  • Metadata
Be the first to leave a comment!
You must be logged in first
  • ikona citování Cite this
  • ikona bookmark Save to List
  • ikona export Export Record
    • Export to CitacePRO
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to RIS
  • ikona email Email this
  • ikona permanent link Permanent link

Search Options

  • Search History
  • Browse the Catalog
  • Browse Alphabetically
  • New Items

Find More with K.UTB

  • Opening Hours of the Library
  • Suggestion for Book Purchase
  • Interlibrary Loans
  • Printing and binding of the Theses

Need Help?

  • Search Tips
  • FAQs
  • Feedback
  • Contacts
logo knihovny

Declaration of Accessibility | Cookies

Knihovna UTB ve Zlíně © 2025